Fresh Rounds

Solaris Endovascular Inc. funding

Solaris Endovascular Inc., a biotechnology company based in Dallas, TX (founded 2024), filed a Form D with the SEC on October 1, 2026 and reported $5M raised of a $10M offering.

Amount raised$5M
Offering size$10M
Filed with the SECOctober 1, 2026
First saleSeptember 5, 2025
IndustryBiotechnology
SecuritiesEquity, Debt, Options or warrants
LocationDallas, TX
Founded2024
Entity typeCorporation
Investors so far45
Minimum investment$2.5K
Revenue rangeDecline to Disclose

Other health care rounds in Texas